in

Zydus Lifesciences’ Usnoflast Gets FDA’s Orphan Drug Status

Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday.

The FDA’s Office of Orphan Drug Products grants orphan status to support the development of…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Union Minister Vaishnaw takes part in series of meetings at WEF 2025

SEBI floats consultation paper on ‘sachetisation’ of mutual funds; seeks public comment